αb-crystallin immunolocalization yields new insights into inclusion body myositis

Neurology

Volumn 54, Issue 5, 2000, Pages 1033-1041

  Banwell, Brenda L ^a,b   Engel, Andrew G ^a  

^a MAYO CLINIC   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Immunolocalization; Inclusion body myositis; Myopathies; T cell response; B crystallin

Indexed keywords

CRYSTALLIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INCLUSION BODY MYOSITIS; MALE; MUSCLE CELL; MUSCLE DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; CHILD; IMMUNOHISTOCHEMISTRY; INFANT; MIDDLE AGED; MUSCLE; PATHOLOGY; PRESCHOOL CHILD;

ADULT; AGED; CHILD; CHILD, PRESCHOOL; CRYSTALLINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MIDDLE AGED; MUSCLES; MYOSITIS, INCLUSION BODY;

EID: 0034646141     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.54.5.1033     Document Type: Article

References (61)

1. Graw J. The crystallins: genes, proteins, and diseases. Biol Chem 1997;378:1331-1348.
2. Kato K, Goto S, Inaguma Y, Hasegawa K, Morishita R, Asano T. Purification and characterization of a 20-kDa protein that is highly homologous to αB-crystallin. J Biol Chem 1994;269: 15302-15309.
3. Iwaki T, Kume-Iwaki A, Goldman JE. Cellular distribution of aB-crystallin in nonlenticular tissues. J Histochem Cytochem 1990;38:31-39.
4. Bennardini F, Wrzosek A, Chiesi M. αB-Crystallin in cardiac tissue. Association with actin and desmin filaments. Circ Res 1992;71:288-294.
5. Arai H, Atomi Y. Chaperone activity of aB-crystallin suppresses tubulin aggregation through complex formation. Cell Struct Funct 1997;22:539-544.
6. Bova MP, Yaron O, Huang Q, et al. Mutation R120G in αB- crystallin, which is linked to a desmin-related myopathy, results in an irregular structure and defective chaperone-like function. Proc Natl Acad Sci USA 1999;96:6137-6142.
7. Muchowski PJ, Clark JI. ATP-enhanced molecular chaperone function of the small heat-shock protein human αB-crystallin. Proc Natl Acad Sci USA 1998;95:1004-1009.
8. Djabali K, De Nechaud B, Landon F, Portier MM. αB-Crystallin interacts with intermediate filaments in response to stress. J Cell Sci 1997;110:2759-2769.
9. Leach IH, Tsang ML, Church RJ, Lowe J. Alpha B-crystallin in the normal human myocardium and cardiac conducting system. J Pathol 1994;173:255-260.
10. Atomi Y, Yamada S, Strohman RC, Nonomura Y. Alpha B-crystallin in skeletal muscle: purification and localization. J Biochem (Tokyo) 1991;110:812-822.
11. Dubin RA, Gopal-Srivastava R, Wawrousek EF, Piatigorsky J. Expression of the murine alpha B-crystallin gene in lens and skeletal muscle: identification of a muscle-preferred enhancer. Mol Cell Biol 1991;11:4340-4349.
12. Lowe J, McDermott H, Pike I, Spendlove I, Landon M, Mayer RJ. Alpha B-crystallin expression in non-lenticular tissues and selective presence in ubiquinated inclusion bodies in human disease. J Pathol 1992;166:61-68.
13. van Sechel AC, Bajramovic JJ, van Stipdonk MJB, Persoon-Deen C, Geutskens SB, van Noort JM. EBV-induced expression and HLA-DR-restricted presentation by human B cells of alpha B-crystallin, a candidate autoantigen in multiple sclerosis. J Immunol 1999;162:129-135.
14. Head MW, Corbin E, Goldman JE. Coordinate and independent regulation of alpha-B-crystallin and hsp27 expression in response to physiological stress. J Cell Physiol 1994;159:41-50.
15. Cairns NJ, Atkinson PF, Hanger DP, Anderton BH, Daniel SE, Lantos PL. Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease. Neurosci Lett 1997;230:49-52.
16. Lowe J. Establishing a pathological diagnosis in degenerative dementias. Brain Pathol 1998;8:403-406.
17. Cooper PN, Jackson M, Lowe J, Mann DM. Tau, ubiquitin, and αB-crystallin immunohistochemistry define the principal causes of degenerative frontotemporal dementia. Arch Neurol 1995;52:1011-1015.
18. Higuchi I, Iwaki T, Tateishi J. Neurodegeneration in the limbic and paralimbic system in progressive supranuclear palsy. Neuropathol Appl Neurobiol 1998;21:246-254.
19. Renkawek K, Voorter CE, Bosman GJ, van Norkum FP, de Jong WW. Expression of αB-crystallin in Alzheimer's disease. Acta Neuropathol (Berl) 1994;87:155-160.
20. Askanas V, Engel WK, Alvarez RB. Fourteen newly recognized proteins at the human neuromuscular junctions and their nonjunctional accumulation in inclusion body myositis. Ann NY Acad Sci 1998;841:28-56.
21. Askanas V, Engel WK. Sporadic inclusion body myositis and its similarities to Alzheimer disease brain. Recent approaches to diagnosis and pathogenesis, and relation to aging. Scand J Rheumatol 1998;27:389-405.
22. Mendell JR, Sahenk Z, Gales L, Paul L. Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments. Arch Neurol 1991;48:1229-1234.
23. Pruitt JN, Showalter CJ, Engel AG. Sporadic inclusion body myositis: counts of different types of abnormal fibers. Ann Neurol 1996;39:139-143.
24. Mikol J, Engel AG. Inclusion body myositis. In: Engel AG, Franzini-Armstrong C, eds. Myology. 2nd ed. New York: McGraw-Hill, 1994:1384-1398.
25. Mirabella M, Alvarez RB, Bilak M, Engel WK, Askanas V. Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion body myopathies. J Neuropathol Exp Neurol 1996;55: 774-786.
26. Engel AG, Hohlfeld R, Banker BQ. Polymyositis and dermatomyositis syndromes. In: Engel AG, Franzini-Armstrong C, eds. Myology. 2nd ed. New York: McGraw-Hill, 1994:1335-1383.
27. De Bleecker JL, Engel AG, Ertl BB. Myofibrillar myopathy with abnormal foci of desmin positivity. II. Immunocytochemical analysis reveals accumulation of multiple other proteins. J Neuropathol Exp Neurol 1996;55:563-577.
28. Engel AG. The muscle biopsy. In: Engel AG, Franzini- Armstrong C, eds. Myology. 2nd ed. New York: McGraw-Hill, 1994:822-831.
29. Askanas V, Engel WK, Alvarez RB. Enhanced detection of Congo red positive amyloid deposits in muscle fibers of inclusion body myositis and brain of Alzheimer's disease using fluorescence technique. Neurology 1993;43:1265-1267.
30. Hohlfeld R, Engel AG. Expression of 65-kd heat shock proteins in the inflammatory myopathies. Ann Neurol 1992;32: 821-823.
31. Yang CC, Alvarez RB, Engel WK, Askanas V. Increase of nitric oxide synthases and nitrotyrosine in inclusion body myositis. NeuroReport 1996;8:153-158.
32. Yang CC, Alvarez RB, Engel WK, Heller SL, Askanas V. Nitric oxide-induced oxidative stress in autosomal recessive and dominant inclusion body myositis. Brain 1998;121:1089-1097.
33. Askanas V, Engel WK. Sporadic inclusion body myositis and hereditary inclusion body myopathies: current concepts of diagnosis and pathogenesis. Curr Opin Rheumatol 1998;10: 530-542.
34. Goebel HH. Desmin-related myopathies. Curr Opin Neurol 1997;10:426-429.
35. Vicart P, Caron A, Guicheney P, et al. A missense mutation in the αB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet 1998;20:92-95.
36. Iwaki T, Iwaki A, Goldman JE. Alpha B-crystallin in oxidative muscle fibers and its accumulation in ragged-red fibers: a comparative immunohistochemical and histochemical study in human skeletal muscle. Acta Neuropathol (Berl) 1993;85:475-480.
37. Showalter CJ, Engel AG. Acute quadriplegic myopathy: analysis of myosin isoforms and evidence for calpain-mediated proteolysis. Muscle Nerve 1997;20:316-322.
38. Scheier B, Foletti A, Stark G, et al. Glucocorticoids regulate the expression of the stressprotein alpha B-crystallin. Mol Cell Endocrinol 1996;123:187-198.
39. Neufer PD, Benjamin IJ. Differential expression of B-crystallin and Hsp27 in skeletal muscle during continuous contractile activity. Relationship to myogenic regulatory factors. J Biol Chem 1996;271:24089-24095.
40. Ito H, Okamoto K, Kato K. Prostaglandins stimulate the stress-induced synthesis of hsp27 and αB-crystallin. J Cell Physiol 1997;170:255-262.
41. Kato K, Ito H, Inaguma Y, Okamoto K, Saga S. Synthesis and accumulation of alpha B-crystallin in C6 glioma cells is induced by agents that promote disassembly of microtubules. J Biol Chem 1996;271:26989-26994.
42. Mehlen P, Kretz-Remy C, Preville X, Arrigo AP. Human hsp27, Drosphila hsp27, and human alpha B-crystallin expression-mediated increase in glutathione is essential for the protective activity of these proteins against TNF alpha- induced cell death. EMBO J 1996;15:2695-2706.
43. Yang CC, Askanas V, Alvarez RB, Engel WK. Immunolocalization of transcription factor NF-kappa B in inclusion body myositis and at normal human neuromuscular junctions. Neurosci Lett 1998;254:77-80.
44. Lundberg I, Brengman JM, Engel AG. Analysis of cytokine expression in inflammatory myopathies, Duchenne dystrophy, and non-weak controls. J Neuroimmunol 1995;63:9-16.
45. Nalbantoglu J, Karpati G, Carpenter S. Conspicuous accumulation of a single-stranded DNA binding protein in skeletal muscle fibers in inclusion body myositis. Am J Pathol 1994; 144:874-882.
46. van Noort JM, van Veelen P, Hopstaken F. Purification of the stress protein alpha B-crystallin and its differentially phosphorylated forms. J Immunol Methods 1998;221:159-168.
47. Carver JA, Nicholls KA, Aquilina JA, Truscott RJ. Age-related changes in bovine alpha-crystallin and high-molecular-weight protein. Exp Eye Res 1996;63:639-647.
48. van Boekel MA, Hoogakker SE, Harding JJ, de Jong WW. The influence of some posttranslational modifications on the chaperone-like activity of alpha-crystallin. Ophthalmic Res 1998;28(suppl 1):32-38.
49. van Stipdonk MJB, Willems AA, Amor S, et al. T cells discriminate between differentially phosphorylated forms of alpha B-crystallin, a major central nervous system myelin antigen. Int Immunol 1998;10:943-950.
50. van Noort JM, van Sechel AC, van Stipdonk MJB, Bajramovic JJ. The small heat shock protein αB-crystallin as key autoantigen in multiple sclerosis. Prog Brain Res 1998;117:435-452.
51. Engelhard VH. Structure of peptides associated with MHC class I molecules. Cur Opin Immunol 1994;6:13-23.
52. Horwitz J. Alpha-crystallin can function as a molecular chaperone. Proc Natl Acad Sci USA 1992;89:10449-10453.
53. Benjamin IJ, McMillan DR. Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease. Circ Res 1998;83:117-132.
54. Nishino H, Engel AG, Rima BK. Inclusion body myositis: the mumps virus hypothesis. Ann Neurol 1989;25:260-264.
55. Fox SA, Ward BK, Robbins PD, Mastaglia FL, Swanson NR. Inclusion body myositis: investigation of the mumps virus hypothesis by polymerase chain reaction. Muscle Nerve 1996;19: 23-28.
56. Leon-Monzon M, Dalakas MC. Absence of persistent infection with enteroviruses in muscles of patients with inflammatory myopathies. Ann Neurol 1992;32:219-222.
57. Hilton DA, Fletcher A, Pringle JH. Absence of coxsackie viruses in idiopathic inflammatory muscle disease by in situ hybridization. Neuropathol Appl Neurobiol 1994;20:238-242.
58. Leff RL, Love LA, Miller FW, et al. Viruses in idiopathic - inflammatory myopathies: absence of candidate viral genomes in muscle. Lancet 1992;339:1192-1195.
59. Engel WK, Haginoya K, Alvarez RB, Sabetian K, Bajoghli M, Askanas V. Sporadic inclusion body myositis in an HTLV-1- positive Iranian Muslim. Neurology 1997;48(suppl 2):A124. Abstract.
60. Cupler E, Leon-Monzon M, Miller J, Semino-Mora C, Anderson T, Dalakas MC. Inclusion body myositis in HIV-1 and HTLV-1 infected patients. Brain 1996;119:1887-1893.
61. Hohlfeld R. Biotechnological agents for the immunotherapy of multiple sclerosis. Principals, problems and perspectives. Brain 1997;120:865-916.